Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michelle L. Gleeson
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare
Journal of Cancer Epidemiology
Environmental
Public Health
Genetics
Epidemiology
Occupational Health
Related publications
Subgroups of High-Cost Medicare Advantage Patients: An Observational Study
Journal of General Internal Medicine
Internal Medicine
An International Comparison of the Efficacy, Cost and Myelotoxicity of First-Line Therapy for Advanced Follicular Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy
BMJ Open
Medicine
Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results
BMC Cancer
Cancer Research
Oncology
Genetics
Cost-Effectiveness of Adding Rituximab to Splenectomy and Romiplostim for Treating Steroid-Resistant Idiopathic Thrombocytopenic Purpura in Adults
BMC Health Services Research
Health Policy
M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy
British Journal of Haematology
Hematology
Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on a Systematic Review and Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
